Use of calcitonin for the treatment of RA
US8835389B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Nov 3, 2006 |
| Grant date | Sep 16, 2014 |
| Priority date | — |
| Expiry date | Dec 10, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel use of calcitonin in rheumatoid arthritis, and to methods of treating and/or preventing rheumatoid arthritis and conditions associated therewith in mammals, particularly humans. In particular, a method is provided of preventing or/and treating rheumatoid arthritis in a patient in need thereof comprising administering to said patient a therapeutically effective amount of calcitonin, e.g. salmon calcitonin in free form or salt form, in a pharmaceutically acceptable oral delivery form, wherein the therapeutically effective amount of a calcitonin is delivered orally in a composition comprising the calcitonin and a delivery agent for calcitonin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.